27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Gainers
- MDJM Ltd. (NASDAQ:MDJH) shares climbed 38% to $3.7246 after the company announced it renewed a Primary Real Estate Agency Services Contract with Tianjin Binhai New City Investment Co.
- Maxar Technologies Inc. (NYSE:MAXR) gained 14.4% to $9.06.
- Ovid Therapeutics Inc (NASDAQ:OVID) climbed 13.1% to $2.6129 after receiving Orphan Drug designation from the European Commission for OV101 for the treatment of Angelman syndrome.
- Revolve Group, Inc. (NYSE:RVLV) surged 13% to $37.06. Jefferies initiated coverage on Revolve Group with a Buy rating, while Morgan Stanley initiated coverage on the stock with an Overweight rating. Raymond James initiated coverage on Revolve with an Outperform rating.
- Aethlon Medical, Inc. (NASDAQ:AEMD) shares gained 13% to $0.4970 after the company reported FY19 EPS and sales up from last year.
- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) gained 12.2% to $16.05. Evercore ISI Group upgraded Dova Pharmaceuticals from In-Line to Outperform.
- Bio-Path Holdings Inc (NASDAQ:BPTH) rose 10.3% to $15.02 after patent site USPTO showed the company received a patent entitled "P-ethoxy nucleic acids for liposomal formulation."
- Reebonz Holding Limited (NASDAQ:RBZ) rose 10.1% to $4.15 after the company expanded its "Sell to Reebonz" service in Malaysia, Indonesia, Hong Kong, Taiwan and Australia.
- Eros International plc (NYSE:EROS) climbed 9.7% to $1.6450 after the company announced that outstanding interest payments of its Indian subsidiary have been paid off.
- Orion Group Holdings, Inc. (NYSE:ORN) rose 9.6% to $2.86.
- Veru Inc. (NASDAQ:VERU) gained 8.4% to $2.3404. Cantor Fitzgerald initiated coverage on Veru with an Overweight rating and a $6 price target.
- Amarin Corporation plc (NASDAQ:AMRN) rose 6.8% to $20.55 after the company raised its FY19 sales guidance.
- Cars.com Inc. (NYSE:CARS) rose 5.7% to $20.99. Citigroup upgraded Cars.com from Neutral to Buy.
Check out these big penny stock gainers and losers
Losers
- OncoCyte Corporation (NYSE:OCX) dropped 21.5% to $1.97.
- CyberOptics Corporation (NASDAQ:CYBE) shares tumbled 20% to $14.30 after the company lowered its Q2 revenue forecast.
- Francesca's Holdings Corporation (NASDAQ:FRAN) dropped 11.8% to $4.67 after the company reported the resignation of CFO Kelly Dilts.
- Acuity Brands, Inc. (NYSE:AYI) dropped 11.7% to $124.47 after the company reported worse-than-expected Q3 sales results.
- The Greenbrier Companies, Inc. (NYSE:GBX) shares fell 11.2% to $27.39 after the company reported downbeat results for its third quarter and issued weak Q4 forecast.
- Seadrill Limited (NYSE:SDRL) dropped 11% to $4.3768.
- CEL-SCI Corporation (NYSE:CVM) shares declined 10.4% to $7.85.
- GTT Communications, Inc. (NYSE:GTT) declined 9.8% to $16.96. KeyBanc downgraded GTT Communications from Overweight to Sector Weight.
- Soliton Inc (NASDAQ:SOLY) fell 9% to $12.58 after the company announced a common stock offering of 1.148 million shares.
- Nabors Industries Ltd. (NYSE:NBR) fell 8.4% to $2.7858.
- BlackLine, Inc. (NASDAQ:BL) fell 8.2% to $48.87. Goldman Sachs downgraded BlackLine from Buy to Sell and lowered the price target from $57 to $41.
- Chaparral Energy, Inc. (NYSE:CHAP) dropped 8% to $4.37.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) shares fell 8% to $5.20.
- ImmunoGen, Inc. (NASDAQ:IMGN) fell 7.5% to $2.1650.
- Ceragon Networks Ltd (NASDAQ:CRNT) dipped 7.3% to $2.8269. Ceragon reported second-quarter revenue will be impacted by a further delay in receiving certain orders from India. The company sees second-quarter revenue in the range of $71 million to $74 million
- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) fell 7% to $3.2200.
- Cemtrex, Inc. (NASDAQ:CETX) shares dropped 7% to $2.3079.
- Melinta Therapeutics, Inc. (NASDAQ:MLNT) fell 6.1% to $6.62 after rising 6.02% on Monday.
- Infrastructure and Energy Alternatives, Inc. (NASDAQ:IEA) fell 5.6% to $2.53 after surging 31.37% on Monday.
- Xenetic Biosciences, Inc. (NASDAQ:XBIO) fell 4% to $10.51. Xenetic Biosciences filed prospectus for offering of 1.6 million shares of common stock & warrants.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!